SOX5 inhibition overcomes PARP inhibitor resistance in BRCA-mutated breast and ovarian cancer

Mithun Ghosh(CHA University), Yong Wha Moon(CHA University Bundang Medical Center)

Cell Death and Disease

April 24, 2025

10.1038/s41419-025-07660-7

Cited by 4

Related Papers

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma

|Oncotarget|2014|34

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.

|PubMed Central|2015|1

JPI-547, a novel dual inhibitor of PARP1/2 and tankyrase is more effective than first-generation PARP inhibitors in preclinical BRCA1/2-mutated cancer models

|British Journal of Cancer|2026|0